The drug Aricept delayed
patients’ progression to
Alzheimer’s disease by a year,
according to an April study in the
New England Journal of Medicine. This is one of the first studies suggesting that this drug may
prove effective in delaying
Alzheimer’s disease, but more
research needs to be completed.
UCLA is part of a National Institute of Aging study that will
further assess Aricept’s role.
UCLA researchers seek
healthy adults 40 to 90 ...
Oops! An active online subscription is required to access this content.
Please login below or Subscribe today!